0001193125-13-262753 Sample Contracts

ONCOGENEX PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At- the-Market Issuance Sales Agreement

Sales Agreement • June 18th, 2013 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Sales Agreement
• Filed
  June 18th, 2013
• Company
  Oncogenex Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

OncoGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: